Showing 1090 – 1100 of 1303 results
-
Akouos Inc Initiation of Research Coverage
William Blair initiated research coverage of Akouos, Inc. (AKUS $5.10), a genetic medicine company focused on the development of AAV-based therapies that restore, preserve, or improve hearing in individuals with sensorineural hearing loss.
-
Apollo Medical Holdings Initiation
William Blair initiated research coverage of Apollo Medical Holdings, Inc. (AMEH $39.14), a physician-led and technology-enabled advanced primary care partner, responsible for coordinating care for more than 1.2 million patients.
-
Sangoma Technologies Corporation Initiation
William Blair initiated research coverage of Sangoma Technologies Corporation (SANG $7.01), a managed service provider with a complete range of integrated, built-in-house solutions for businesses.
-
Five9 Inc Initiation
William Blair initiated research coverage of Five9, Inc. (FIVN $120.60), which provides cloud contact center technology and solutions to businesses of all sizes.
-
BigBearai Holdings Inc Initiation
William Blair initiated research coverage of BigBear.ai Holdings, Inc. (BBAI $5.20), a provider of data analytics and IT solutions for the U.S. government.
-
Simulations Plus Inc Initiation
William Blair initiated research coverage of Simulations Plus, Inc. (SLP $47.70), a leading global developer of biosimulation software and services.
-
Telix Pharmaceuticals Limited
William Blair initiated research coverage of Telix Pharmaceuticals Limited (TLX-ASX AUD 19.22), a commercial-stage radiopharmaceuticals company that markets Illuccix for imaging prostate cancer and may, pending regulatory approval, also market imaging agents for renal masses and glioblastoma.
-
Zevra Therapeutics Inc Initiation
William Blair initiated research coverage of Zevra Therapeutics, Inc. (ZVRA $6.10), a rare-disease therapeutics company.
-
ManpowerGroup Inc Initiation
William Blair initiated research coverage of ManpowerGroup Inc. (MAN $77.68), a leading global provider of staffing services and other talent solutions.
-
Fortrea Holdings Inc.: Initiation of Research Coverage
William Blair initiated research coverage of Fortrea Holdings Inc. (FTRE $33.00), a global clinical research organization (CRO) providing comprehensive Phase I through Phase IV biopharmaceutical product and medical device services, patient access solutions, and other enabling services.